Revenue Integrity

Use this sample language as a guide when developing or reviewing payer contracts.

CMS is proposing a coverage pathway to achieve expedited and more predictable access to new medical technologies for Medicare beneficiaries.

As part of 2023 Revenue Integrity Week (June 5-9), NAHRI opened nominations to its Peer Recognition Program to recognize revenue integrity professionals for their contributions to the field and for the ways in which they have helped their peers. Learn more about the nominees.

A group of senators recently sent a letter to stakeholders to seek input on improving the 340B drug pricing program.

Ronald Hirsch, MD, FACP, CHCQM, CHRI, discusses strategies for complying with payers' rules for observation services.

CMS recently released a list of the 43 Part B drugs and biologicals that will be included in the Medicare Prescription Drug Inflation Rebate Program for July 1–September 30.

Providers must do everything in their power to prevent payers from conducting a high number of audits at their organization.